MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia-Guzman, M.
Right arrow Articles by Stühmer, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia-Guzman, M.
Right arrow Articles by Stühmer, W.

0026-895X/97/010109-10$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:109-118 (1997).

Characterization of Recombinant Human P2X4 Receptor Reveals Pharmacological Differences to the Rat Homologue

Miguel Garcia-Guzman, Florentina Soto, Juan Manuel Gomez-Hernandez, Per-Eric Lund, and Walter Stühmer

Department of Molecular Biology of Neuronal Signals, Max-Planck Institute for Experimental Medicine, Hermann-Rein-Str. 3, D-37075 Göttingen, Germany

We isolated a cDNA from human brain encoding a purinergic receptor that shows a high degree of homology to the rat P2X4 receptor (87% identity). By fluorescence in situ hybridization, the human P2X4 gene has been mapped to region q24.32 of chromosome 12. Tissue distribution analysis of human P2X4 transcripts demonstrates a broad expression pattern in that the mRNA was detected not only in brain but also in all tissues tested. Heterologous expression of the human P2X4 receptor in Xenopus laevis oocytes and human embryonic kidney 293 cells evoked an ATP-activated channel. Simultaneous whole-cell current and Fura-2 fluorescence measurements in human embryonic kidney 293 cells transfected with human P2X4 cDNA allowed us to determine the fraction of the current carried by Ca2+; this was ~8%, demonstrating a high Ca2+ permeability. Low extracellular Zn2+ concentrations (5-10 µM) increase the apparent gating efficiency of human P2X4 by ATP without affecting the maximal response. However, raising the concentration of the divalent cation (>100 µM) inhibits the ATP-evoked current in a non-voltage-dependent manner. The human P2X4 receptor displays a very similar agonist potency profile to that of rat P2X4 (ATP >>  2-methylthio-ATP >=  CTP > alpha ,beta -methylene-ATP > dATP) but has a notably higher sensitivity for the antagonists suramin, pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid, and bromphenol blue. Chimeric constructs between human and rat isoforms as well as single-point mutations were engineered to map the regions responsible for the different sensitivity to suramin and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. Donnelly-Roberts, S. McGaraughty, C.-C. Shieh, P. Honore, and M. F. Jarvis
Painful Purinergic Receptors
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Zhang, D. Sanchez, J. Gorelik, D. Klenerman, M. Lab, C. Edwards, and Y. Korchev
Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+ channel activity in renal epithelia
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1734 - F1740.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Toulme, F. Soto, M. Garret, and E. Boue-Grabot
Functional Properties of Internalization-Deficient P2X4 Receptors Reveal a Novel Mechanism of Ligand-Gated Channel Facilitation by Ivermectin
Mol. Pharmacol., February 1, 2006; 69(2): 576 - 587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Ohta, A. Kubota, M. Murakami, K.-i. Otsuguro, and S. Ito
P2X2 receptors are essential for [Ca2+]i increases in response to ATP in cultured rat myenteric neurons
Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G935 - G948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Kelvin. C. Agboh, T. E. Webb, R. J. Evans, and S. J. Ennion
Functional Characterization of a P2X Receptor from Schistosoma mansoni
J. Biol. Chem., October 1, 2004; 279(40): 41650 - 41657.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Brown, J. I. E. Bruce, S. V. Straub, and D. I. Yule
cAMP Potentiates ATP-evoked Calcium Signaling in Human Parotid Acinar Cells
J. Biol. Chem., September 17, 2004; 279(38): 39485 - 39494.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Watano, J. A. Calvert, C. Vial, I. D. Forsythe, and R. J. Evans
P2X receptor subtype-specific modulation of excitatory and inhibitory synaptic inputs in the rat brainstem
J. Physiol., August 1, 2004; 558(3): 745 - 757.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
A. Priel and S. D. Silberberg
Mechanism of Ivermectin Facilitation of Human P2X4 Receptor Channels
J. Gen. Physiol., February 23, 2004; 123(3): 281 - 293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic
Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C467 - C479.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. North
Molecular Physiology of P2X Receptors
Physiol Rev, October 1, 2002; 82(4): 1013 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Gabriels, K. H. Rahn, E. Schlatter, and M. Steinmetz
Mesenteric and renal vascular effects of diadenosine polyphosphates (APnA)
Cardiovasc Res, October 1, 2002; 56(1): 22 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Steinmetz, A.-K. Janssen, F. Pelster, K. H. Rahn, and E. Schlatter
Vasoactivity of Diadenosine Polyphosphates in Human Small Mesenteric Resistance Arteries
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Ramirez and D. L. Kunze
P2X purinergic receptor channel expression and function in bovine aortic endothelium
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2106 - H2116.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. D. Clyne, L.-F. Wang, and R. I. Hume
Mutational Analysis of the Conserved Cysteines of the Rat P2X2 Purinoceptor
J. Neurosci., May 15, 2002; 22(10): 3873 - 3880.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Ennion and R. J. Evans
Conserved Cysteine Residues in the Extracellular Loop of the Human P2X1 Receptor Form Disulfide Bonds and Are Involved in Receptor Trafficking to the Cell Surface
Mol. Pharmacol., February 1, 2002; 61(2): 303 - 311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. I. Gorodeski
Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms
Am J Physiol Cell Physiol, January 1, 2002; 282(1): C75 - C83.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Korenaga, K. Yamamoto, N. Ohura, T. Sokabe, A. Kamiya, and J. Ando
Sp1-mediated downregulation of P2X4 receptor gene transcription in endothelial cells exposed to shear stress
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2214 - H2221.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. E. Rubio and F. Soto
Distinct Localization of P2X Receptors at Excitatory Postsynaptic Specializations
J. Neurosci., January 15, 2001; 21(2): 641 - 653.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Yamamoto, R. Korenaga, A. Kamiya, and J. Ando
Fluid Shear Stress Activates Ca2+ Influx Into Human Endothelial Cells via P2X4 Purinoceptors
Circ. Res., September 1, 2000; 87(5): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-Z. Shen, X.-F. Zheng, and C.-Y. Kwan
Evidence for P2-purinoceptors contribution in H2O2-induced contraction of rat aorta in the absence of endothelium
Cardiovasc Res, August 18, 2000; 47(3): 574 - 585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L.-H. Jiang, A. B. Mackenzie, R. A. North, and A. Surprenant
Brilliant Blue G Selectively Blocks ATP-Gated Rat P2X7 Receptors
Mol. Pharmacol., July 1, 2000; 58(1): 82 - 88.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Yamamoto, R. Korenaga, A. Kamiya, Z. Qi, M. Sokabe, and J. Ando
P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H285 - H292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D.-M. Zhao, H.-H. Xue, K. Chida, T. Suda, Y. Oki, M. Kanai, C. Uchida, A. Ichiyama, and H. Nakamura
Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L726 - L736.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Hede, J. Amstrup, B. C. Christoffersen, and I. Novak
Purinoceptors Evoke Different Electrophysiological Responses in Pancreatic Ducts. P2Y INHIBITS K+ CONDUCTANCE, AND P2X STIMULATES CATION CONDUCTANCE
J. Biol. Chem., November 5, 1999; 274(45): 31784 - 31791.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. P. Schilling, T. Wasylyna, G. R. Dubyak, B. D. Humphreys, and W. G. Sinkins
Maitotoxin and P2Z/P2X7 purinergic receptor stimulation activate a common cytolytic pore
Am J Physiol Cell Physiol, October 1, 1999; 277(4): C766 - C776.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Xiong, R. W. Peoples, J. P. Montgomery, Y. Chiang, R. R. Stewart, F. F. Weight, and C. Li
Differential Modulation by Copper and Zinc of P2X2 and P2X4 Receptor Function
J Neurophysiol, May 1, 1999; 81(5): 2088 - 2094.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Naemsch, A. Weidema, S. Sims, T. Underhill, and S. Dixon
P2X(4) purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts
J. Cell Sci., January 12, 1999; 112(23): 4425 - 4435.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
A Solini, P Chiozzi, A Morelli, R Fellin, and F Di Virgilio
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release
J. Cell Sci., January 2, 1999; 112(3): 297 - 305.
[Abstract] [PDF]


Home page
BloodHome page
G. Buell, I.P. Chessell, A.D. Michel, G. Collo, M. Salazzo, S. Herren, D. Gretener, C. Grahames, R. Kaur, M.H. Kosco-Vilbois, et al.
Blockade of Human P2X7 Receptor Function With a Monoclonal Antibody
Blood, November 15, 1998; 92(10): 3521 - 3528.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. D. Humphreys, C. Virginio, A. Surprenant, J. Rice, and G. R. Dubyak
Isoquinolines as Antagonists of the P2X7 Nucleotide Receptor: High Selectivity for the Human versus Rat Receptor Homologues
Mol. Pharmacol., July 1, 1998; 54(1): 22 - 32.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Newbolt, R. Stoop, C. Virginio, A. Surprenant, R. A. North, G. Buell, and F. Rassendren
Membrane Topology of an ATP-gated Ion Channel (P2X Receptor)
J. Biol. Chem., June 12, 1998; 273(24): 15177 - 15182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. W. Inscho, A. K. Cook, V. Mui, and J. Miller
Direct assessment of renal microvascular responses to P2-purinoceptor agonists
Am J Physiol Renal Physiol, April 1, 1998; 274(4): F718 - F727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ennion, S. Hagan, and R. J. Evans
The Role of Positively Charged Amino Acids in ATP Recognition by Human P2X1 Receptors
J. Biol. Chem., September 15, 2000; 275(38): 29361 - 29367.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-H. Jiang, F. Rassendren, A. Surprenant, and R. A. North
Identification of Amino Acid Residues Contributing to the ATP-binding Site of a Purinergic P2X Receptor
J. Biol. Chem., October 27, 2000; 275(44): 34190 - 34196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. R. Haines, K. Migita, J. A. Cox, T. M. Egan, and M. M. Voigt
The First Transmembrane Domain of the P2X Receptor Subunit Participates in the Agonist-induced Gating of the Channel
J. Biol. Chem., August 24, 2001; 276(35): 32793 - 32798.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Ramirez and D. L. Kunze
P2X purinergic receptor channel expression and function in bovine aortic endothelium
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2106 - H2116.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics